Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors

NCT04083781 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04083781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04083781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With Inhibitors
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 21, 2019
Completion date
February 21, 2027
Enrollment
134 (actual)
Sites
99

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a with inhibitors, haemophilia b with inhibitors